The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, open-label, dose-escalation study of SNX-5422 plus carboplatin and paclitaxel in subjects with advanced lung cancers.
 
Martin Gutierrez
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Giuseppe Giaccone
Consulting or Advisory Role - Astex Pharmaceuticals; AVEO; Boehringer Ingelheim; Clovis Oncology
 
Harry D. Harper
Employment - Northern New Jersey Cancer Associates
Stock and Other Ownership Interests - GK Hackensack; Northern New Jersey Cancer Associates
Honoraria - Boehringer Ingelheim; Lilly
Speakers' Bureau - Boehringer Ingelheim; Lilly
 
Stephen V. Liu
Consulting or Advisory Role - Biodesix; Genentech; Perthera
 
Bruno Fang
Employment - Regional Cancer Care Associates
Leadership - Regional Cancer Care Associates
Stock and Other Ownership Interests - COTA
Travel, Accommodations, Expenses - ION Pharma
 
Jimmy Ruiz
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
James M Hinson
Consulting or Advisory Role - Esanex
 
Everardus Otto Orlemans
Employment - Esanex
Leadership - Esanex
Stock and Other Ownership Interests - Esanex
Patents, Royalties, Other Intellectual Property - Esanex
 
Alexander E. Drilon
Honoraria - Exelixis; Genentech/Roche; Ignyta
Consulting or Advisory Role - Exelixis; Genentech/Roche
Speakers' Bureau - Ignyta
Research Funding - Foundation Medicine
Travel, Accommodations, Expenses - Exelixis; Genentech/Roche; Ignyta